Literature DB >> 27185048

Pilot evaluation of ivacaftor for chronic bronchitis.

George M Solomon1, Heather Hathorne2, Bo Liu2, S Vamsee Raju1, Ginger Reeves2, Edward P Acosta3, Mark T Dransfield4, Steven M Rowe5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27185048      PMCID： PMC4916910          DOI： 10.1016/S2213-2600(16)30047-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  13 in total

1.  Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD.

Authors:  Amany F Elbehairy; Natya Raghavan; Sicheng Cheng; Ling Yang; Katherine A Webb; J Alberto Neder; Jordan A Guenette; Mahmoud I Mahmoud; Denis E O'Donnell
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

2.  Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.

Authors:  Clifford A Courville; S Vamsee Raju; Bo Liu; Frank J Accurso; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

3.  Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

Authors:  Steven M Rowe; Sonya L Heltshe; Tanja Gonska; Scott H Donaldson; Drucy Borowitz; Daniel Gelfond; Scott D Sagel; Umer Khan; Nicole Mayer-Hamblett; Jill M Van Dalfsen; Elizabeth Joseloff; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

4.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Authors:  Bonnie W Ramsey; Jane Davies; N Gerard McElvaney; Elizabeth Tullis; Scott C Bell; Pavel Dřevínek; Matthias Griese; Edward F McKone; Claire E Wainwright; Michael W Konstan; Richard Moss; Felix Ratjen; Isabelle Sermet-Gaudelus; Steven M Rowe; Qunming Dong; Sally Rodriguez; Karl Yen; Claudia Ordoñez; J Stuart Elborn
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

5.  Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Authors:  Richard B Moss; Patrick A Flume; J Stuart Elborn; Jon Cooke; Steven M Rowe; Susanna A McColley; Ronald C Rubenstein; Mark Higgins
Journal:  Lancet Respir Med       Date:  2015-06-09       Impact factor: 30.700

6.  Factors associated with bronchiectasis in patients with COPD.

Authors:  Miguel Ángel Martínez-García; Juan José Soler-Cataluña; Yolanda Donat Sanz; Pablo Catalán Serra; Marcos Agramunt Lerma; Javier Ballestín Vicente; Miguel Perpiñá-Tordera
Journal:  Chest       Date:  2011-05-05       Impact factor: 9.410

7.  Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.

Authors:  S Vamsee Raju; Patricia L Jackson; Clifford A Courville; Carmel M McNicholas; Peter A Sloane; Gina Sabbatini; Sherry Tidwell; Li Ping Tang; Bo Liu; James A Fortenberry; Caleb W Jones; Jeremy A Boydston; J P Clancy; Larry E Bowen; Frank J Accurso; J Edwin Blalock; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

8.  Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.

Authors:  Mark T Dransfield; Andrew M Wilhelm; Brian Flanagan; Clifford Courville; Sherry L Tidwell; S Vamsee Raju; Amit Gaggar; Chad Steele; Li Ping Tang; Bo Liu; Steven M Rowe
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

9.  The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation.

Authors:  Nancy Kline Leidy; Stephen I Rennard; Jordana Schmier; M Kathryn C Jones; Mitch Goldman
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

10.  Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.

Authors:  Clifford A Courville; Sherry Tidwell; Bo Liu; Frank J Accurso; Mark T Dransfield; Steven M Rowe
Journal:  Respir Res       Date:  2014-02-25
View more
  16 in total

1.  Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia.

Authors:  Vivian Y Lin; Matthew D Fain; Patricia L Jackson; Taylor F Berryhill; Landon S Wilson; Marina Mazur; Stephen J Barnes; J Edwin Blalock; S Vamsee Raju; Steven M Rowe
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

Review 2.  Seeing cilia: imaging modalities for ciliary motion and clinical connections.

Authors:  Jacelyn E Peabody; Ren-Jay Shei; Brent M Bermingham; Scott E Phillips; Brett Turner; Steven M Rowe; George M Solomon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-01       Impact factor: 5.464

Review 3.  The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Authors:  George M Solomon; Lianwu Fu; Steven M Rowe; James F Collawn
Journal:  Curr Opin Pharmacol       Date:  2017-11-10       Impact factor: 5.547

4.  Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer.

Authors:  Jennifer S Guimbellot; Edward P Acosta; Steven M Rowe
Journal:  Pediatr Pulmonol       Date:  2018-02-28

5.  Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy.

Authors:  Jennifer S Guimbellot; Kevin J Ryan; Justin D Anderson; Zhongyu Liu; Latona Kersh; Charles R Esther; Steven M Rowe; Edward P Acosta
Journal:  J Cyst Fibros       Date:  2020-02-07       Impact factor: 5.482

6.  Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction and Radiographic Bronchiectasis in Current and Former Smokers: A Cross-Sectional Study.

Authors:  Krittika Teerapuncharoen; J Michael Wells; S Vamsee Raju; Karen S Raraigh; Melis Atalar Aksit; Garry R Cutting; Lawrence Rasmussen; P Hrudaya Nath; Surya P Bhatt; George M Solomon; Mark T Dransfield; Steven M Rowe
Journal:  Ann Am Thorac Soc       Date:  2019-01

Review 7.  Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Juan Shi; Hui Li; Chao Yuan; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Oxid Med Cell Longev       Date:  2018-04-23       Impact factor: 6.543

8.  Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.

Authors:  S Vamsee Raju; Lawrence Rasmussen; Peter A Sloane; Li Ping Tang; Emily Falk Libby; Steven M Rowe
Journal:  Respir Res       Date:  2017-09-18

9.  The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report.

Authors:  J Dixon Johns; Steven M Rowe
Journal:  BMC Gastroenterol       Date:  2019-07-11       Impact factor: 3.067

10.  Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress.

Authors:  Daniel S Aridgides; Diane L Mellinger; David A Armstrong; Haley F Hazlett; John A Dessaint; Thomas H Hampton; Graham T Atkins; James L Carroll; Alix Ashare
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.